Melinta

Melinta is a biotechnology company that develops and commercializes novel antibiotics for the treatment of bacterial infections.

Business Model:

Revenue: $96.4M

Employees: 201-500

Detailed Melinta Information

Melinta was acquired by Cempra.
The acquisition happend on 2017-08-09.
Details of the transaction were not public

Acquirer

Geographic Data

Melinta headquarters map

Address: 44 Whippany Road

City: Morristown

State: NJ

Zip: 07960

Country: US

Financial Info

Stage:

post ipo equity

Raised Last:

$123M

Raised Total:

$558M

Metrics

3,977,674Website Global Rank

3,024Website Monthly Traffic

Twitter Followers

Description

Melinta is a biotechnology company that develops and commercializes novel antibiotics for the treatment of bacterial infections.

Contact Phone:
+18446336568

Contact Email:

Melinta went public on 11/6/2017 on the NASDAQ

Listed Exchange:
NASDAQ

IPO Date:
11/6/2017

Ticker Symbol:
MLNT

Live

Opened: -/share

EBITDA -
Total Cash -
Total Debt -
Total Revenue -
Total Profit (Gross) -
PE Ratio -
Announced Date Company Transaction Money Raised
Announced Date Transaction Number of Investors Money Raised Lead Investors
2/2014 Post-IPO Equity $0 Falcon Flight
Vatera Healthcare Partners
Vatera Healthcare Partners
Falcon Flight
Vatera Healthcare Partners
Vatera Healthcare Partners
1/2018 Post-IPO Equity $137.8M Oberland Capital Management LLC
Vatera Healthcare Partners LLC
11/2017 Post-IPO Debt 1 $240M Deerfield
Deerfield
Deerfield
Deerfield
2/2015 Post-IPO Debt 1 $30M Hercules Capital
Hercules Capital
11/2012 Post-IPO Equity 4 $67.5M ABS Ventures
Vox Equity Partners I
Vatera Healthcare Partners
Warburg Pincus
ABS Ventures
Vox Equity Partners I
Vatera Healthcare Partners
6/2006 Series C $0 ABS Ventures
Axiom Ventures
Cardinal Partners
EuclidSR Partners
Oxford Bioscience Partners
SR One
Warburg Pincus
ABS Ventures
Axiom Ventures
Cardinal Partners
EuclidSR Partners
Oxford Bioscience Partners
SR One
Warburg Pincus
5/2003 Series B 1 $63.5M Warburg Pincus
Warburg Pincus
6/2015 Post-IPO Equity 2 $67M Malin Corporation
Vatera Healthcare Partners
Malin Corporation
Vatera Healthcare Partners
Malin Corporation
1/2002 Series A 3 $22M SR One
Oxford Bioscience Partners
EuclidSR Partners
SR One
Oxford Bioscience Partners
EuclidSR Partners
2/2019 Post-IPO Debt $75M Vatera Healthcare Partners
1/2009 Series D $0 ABS Ventures
Axiom Ventures
EuclidSR Partners
MedImmune Ventures
Oxford Bioscience Partners
SR One
Vox Equity Partners I
Warburg Pincus
ABS Ventures
Axiom Ventures
EuclidSR Partners
MedImmune Ventures
Oxford Bioscience Partners
SR One
Vox Equity Partners I
Warburg Pincus
6/2015 Equity $35M Malin Corporation plc
2/2012 Post-IPO Equity 1 $3M Sanofi
Sanofi
5/2018 Post-IPO Equity $123.2M
6/2017 Post-IPO Equity $0 Oberland Capital
Oberland Capital
Oberland Capital
Oberland Capital
1/2011 Series E 1 $20M Warburg Pincus
Warburg Pincus
5/2018 Grant 1 $6.2M CARB-X
CARB-X
CARB-X
CARB-X
2/2014 Equity 2 $70M Vatera Healthcare Partners LLC
Falcon Flight
Vatera Healthcare Partners
Vatera Healthcare Partners
6/2017 Post-IPO Equity 1 $90M Oberland Capital
Oberland Capital
Oberland Capital
Oberland Capital

Employee Departments

Employee States

Uniview Singapore VEID Logo
Uniview Singapore VEID
Revenue: 0 - 100000
Employees:
Industry: Software
Details
Konkuk University Medical Center Logo
Konkuk University Medical Center
Revenue: 0 - 100000
Employees: 51 - 500
Industry: Education
Details
Daemon Technologies Logo
Daemon Technologies
Revenue: 0 - 100000
Employees: 1 - 10
Industry: Blockchain
Details
Ace International Trade Logo
Ace International Trade
Revenue: 0 - 100000
Employees: 11 - 50
Industry: Industrial
Details
An Hòa Communications Logo
An Hòa Communications
Revenue: 0 - 100000
Employees: 1 - 10
Industry: Advertising
Details

You know, we could be doing all this for you..

CoBee's Logo

Be ahead of your competition

  • Realtime intelligence
  • Automated contact tracking
  • Unmatched insights
  • Eliminate manual research